within Pharmacolibrary.Drugs.ATC.V;

model V03AB36
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.8333333333333333,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0.0019,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Phentolamine is a non-selective alpha-adrenergic antagonist used historically for the management of hypertensive emergencies, especially associated with pheochromocytoma and extravasation of vasoconstrictors. It is also used diagnostically in the pheochromocytoma challenge test. As of today, it is approved and available in some countries but is not widely used in general clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data primarily based on healthy adult subjects, intravenous administration.</p><h4>References</h4><ol><li><p>Moore, PA, et al., &amp; Navalta, L (2008). Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylate. <i>Anesthesia progress</i> 55(2) 40–48. DOI:<a href=&quot;https://doi.org/10.2344/0003-3006(2008)55[40:POLWEF]2.0.CO;2&quot;>10.2344/0003-3006(2008)55[40:POLWEF]2.0.CO;2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18547152/&quot;>https://pubmed.ncbi.nlm.nih.gov/18547152</a></p></li><li><p>Elliott, A, et al., &amp; Gosselin, S (2017). Intraosseous administration of antidotes - a systematic review. <i>Clinical toxicology (Philadelphia, Pa.)</i> 55(10) 1025–1054. DOI:<a href=&quot;https://doi.org/10.1080/15563650.2017.1337122&quot;>10.1080/15563650.2017.1337122</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28644688/&quot;>https://pubmed.ncbi.nlm.nih.gov/28644688</a></p></li><li><p>Jennings, G, et al., &amp; Korner, P (1983). Cardioselectivity of prenalterol and isoproterenol. <i>Clinical pharmacology and therapeutics</i> 34(6) 749–757. DOI:<a href=&quot;https://doi.org/10.1038/clpt.1983.245&quot;>10.1038/clpt.1983.245</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6641090/&quot;>https://pubmed.ncbi.nlm.nih.gov/6641090</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V03AB36;
